| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.981 | 0.003 | 0.99 | Analgesic | 0.99 0.003 DBMET00424 0.975 0.004 DBMET03370 0.927 0.004 DBMET03369 | DBMET00424 | |
| 0.973 | 0.001 | 0.973 | Opioid antagonist | 0.951 0.001 DBMET00424 0.93 0.001 DBMET03370 0.844 0.002 DBMET03369 | ||
| 0.973 | 0.001 | 0.973 | Opioid mu receptor antagonist | 0.946 0.001 DBMET00424 0.922 0.001 DBMET03370 0.813 0.002 DBMET03369 | ||
| 0.971 | 0.001 | 0.987 | Analgesic, opioid | 0.987 0.001 DBMET00424 0.947 0.002 DBMET03370 0.836 0.002 DBMET03369 | DBMET00424 | |
| 0.954 | 0.001 | 0.954 | Opioid delta receptor antagonist | 0.916 0.001 DBMET00424 0.895 0.001 DBMET03370 0.782 0.002 DBMET03369 | ||
| 0.942 | 0.001 | 0.955 | Opioid agonist | 0.955 0.001 DBMET00424 0.912 0.001 DBMET03370 0.798 0.002 DBMET03369 | DBMET00424 | |
| 0.922 | 0.001 | 0.922 | Opioid kappa receptor antagonist | 0.887 0.001 DBMET00424 0.853 0.001 DBMET03370 0.753 0.001 DBMET03369 | ||
| 0.916 | 0.001 | 0.924 | Opioid mu receptor agonist | 0.924 0.001 DBMET00424 0.871 0.001 DBMET03370 0.747 0.002 DBMET03369 | DBMET00424 | |
| 0.903 | 0.001 | 0.954 | Opioid delta receptor agonist | 0.954 0.001 DBMET00424 0.814 0.002 DBMET03370 0.706 0.002 DBMET03369 | DBMET00424 | |
| 0.842 | 0.003 | 0.842 | Sigma receptor antagonist | 0.752 0.003 DBMET00424 0.777 0.003 DBMET03370 0.465 0.004 DBMET03369 | ||
| 0.805 | 0.002 | 0.813 | Antipruritic | 0.756 0.003 DBMET00424 0.813 0.002 DBMET03370 0.575 0.004 DBMET03369 | DBMET03370 | |
| 0.768 | 0.001 | 0.768 | Opioid kappa receptor agonist | 0.733 0.001 DBMET00424 0.699 0.001 DBMET03370 0.569 0.002 DBMET03369 | ||
| 0.752 | 0.002 | 0.752 | Toll-Like receptor antagonist | 0.561 0.003 DBMET00424 0.534 0.003 DBMET03370 0.368 0.005 DBMET03369 | ||
| 0.702 | 0.02 | 0.911 | Transcription factor NF kappa B inhibitor | 0.615 0.029 DBMET00424 0.662 0.025 DBMET03370 0.911 0.005 DBMET03369 | DBMET03369 | |
| 0.672 | 0.001 | 0.672 | Toll-Like receptor 4 antagonist | 0.625 0.001 DBMET00424 0.53 0.001 DBMET03370 0.559 0.001 DBMET03369 | ||
| 0.58 | 0.003 | 0.58 | Acetylcholine M1 receptor antagonist | 0.365 0.008 DBMET00424 0.576 0.003 DBMET03370 0.229 0.031 DBMET03369 | ||
| 0.531 | 0.009 | 0.687 | Psychostimulant | 0.687 0.004 DBMET00424 0.413 0.02 DBMET03370 0.598 0.006 DBMET03369 | DBMET00424 | |
| 0.529 | 0.007 | 0.551 | Sigma receptor agonist | 0.136 0.096 DBMET00424 0.551 0.005 DBMET03370 0.335 0.033 DBMET03369 | DBMET03370 | |
| 0.493 | 0.024 | 0.756 | Spasmolytic | 0.35 0.052 DBMET00424 0.756 0.005 DBMET03370 0.552 0.018 DBMET03369 | DBMET03370 | |
| 0.448 | 0.012 | 0.51 | Anesthetic general | 0.51 0.007 DBMET00424 0.48 0.009 DBMET03370 0.345 0.025 DBMET03369 | DBMET00424 | |
| 0.399 | 0.005 | 0.399 | Toll-Like receptor 9 antagonist | 0.285 0.015 DBMET00424 0.206 0.033 DBMET03370 | ||
| 0.395 | 0.065 | 0.566 | Immunosuppressant | 0.566 0.018 DBMET00424 0.475 0.04 DBMET03370 0.5 0.033 DBMET03369 | DBMET00424 | |
| 0.339 | 0.033 | 0.472 | Nitric oxide antagonist | 0.3 0.04 DBMET00424 0.352 0.031 DBMET03370 0.472 0.018 DBMET03369 | DBMET03369 | |
| 0.311 | 0.005 | 0.688 | Cyclooxygenase 3 inhibitor | 0.352 0.005 DBMET00424 0.261 0.008 DBMET03370 0.688 0.002 DBMET03369 | DBMET03369 | |
| 0.307 | 0.007 | 0.432 | Breast cancer-resistant protein inhibitor | 0.432 0.005 DBMET00424 0.266 0.009 DBMET03370 0.113 0.044 DBMET03369 | DBMET00424 | |
| 0.256 | 0.014 | 0.265 | Acetylcholine muscarinic antagonist | 0.159 0.039 DBMET00424 0.265 0.012 DBMET03370 | DBMET03370 | |
| 0.248 | 0.021 | 0.257 | Cholinergic antagonist | 0.193 0.034 DBMET00424 0.257 0.02 DBMET03370 | DBMET03370 | |
| 0.246 | 0.021 | 0.254 | Acetylcholine antagonist | 0.189 0.034 DBMET00424 0.254 0.019 DBMET03370 | DBMET03370 | |
| 0.249 | 0.041 | 0.268 | P-glycoprotein inhibitor | 0.268 0.036 DBMET00424 0.215 0.056 DBMET03370 0.221 0.053 DBMET03369 | DBMET00424 | |
| 0.224 | 0.027 | 0.289 | Acetylcholinesterase inhibitor | 0.289 0.014 DBMET00424 0.165 0.047 DBMET03370 0.113 0.085 DBMET03369 | DBMET00424 | |
| 0.284 | 0.087 | 0.32 | Caspase 3 stimulant | 0.206 0.16 DBMET00424 0.32 0.07 DBMET03370 0.273 0.094 DBMET03369 | DBMET03370 | |
| 0.191 | 0.004 | 0.194 | Nociceptin (N/OFQ) receptor antagonist | 0.18 0.004 DBMET00424 0.194 0.004 DBMET03370 0.04 0.021 DBMET03369 | DBMET03370 | |
| 0.223 | 0.037 | 0.362 | Cholinergic | 0.362 0.012 DBMET00424 0.176 0.059 DBMET03370 | DBMET00424 | |
| 0.26 | 0.078 | 0.547 | Antioxidant | 0.244 0.087 DBMET00424 0.405 0.034 DBMET03370 0.547 0.015 DBMET03369 | DBMET03369 | |
| 0.26 | 0.091 | 0.321 | Hypoxia-inducible factor 1 alpha inhibitor | 0.321 0.056 DBMET03370 0.248 0.102 DBMET03369 | DBMET03370 | |
| 0.222 | 0.053 | 0.386 | Hepatoprotectant | 0.197 0.067 DBMET00424 0.304 0.028 DBMET03370 0.386 0.014 DBMET03369 | DBMET03369 | |
| 0.165 | 0.013 | 0.165 | Dopamine agonist | 0.157 0.014 DBMET03370 0.059 0.053 DBMET03369 | ||
| 0.171 | 0.022 | 0.212 | Antineoplastic alkaloid | 0.212 0.01 DBMET00424 0.176 0.02 DBMET03370 0.088 0.057 DBMET03369 | DBMET00424 | |
| 0.131 | 0.005 | 0.131 | CC chemokine 5 receptor agonist | 0.11 0.013 DBMET00424 0.127 0.006 DBMET03370 | ||
| 0.132 | 0.008 | 0.132 | Dopamine D2 agonist | 0.122 0.008 DBMET03370 0.079 0.014 DBMET03369 | ||
| 0.21 | 0.089 | 0.474 | Free radical scavenger | 0.199 0.098 DBMET00424 0.344 0.04 DBMET03370 0.474 0.019 DBMET03369 | DBMET03369 | |
| 0.143 | 0.025 | 0.16 | Prolactin inhibitor | 0.115 0.042 DBMET00424 0.16 0.018 DBMET03370 | DBMET03370 | |
| 0.109 | 0.004 | 0.111 | Prolactin release inhibitor | 0.077 0.014 DBMET00424 0.111 0.004 DBMET03370 0.086 0.008 DBMET03369 | DBMET03370 | |
| 0.134 | 0.033 | 0.134 | Estrogen antagonist | 0.126 0.044 DBMET00424 0.129 0.04 DBMET03370 0.106 0.084 DBMET03369 | ||
| 0.138 | 0.038 | 0.155 | Nav1.1 sodium channel blocker | 0.155 0.031 DBMET03370 | DBMET03370 | |
| 0.099 | 0.004 | 0.101 | Nociceptin (N/OFQ) receptor agonist | 0.101 0.004 DBMET00424 0.101 0.004 DBMET03370 0.019 0.016 DBMET03369 | DBMET03370 | |
| 0.101 | 0.009 | 0.101 | Dopamine D5 antagonist | 0.043 0.03 DBMET00424 0.09 0.01 DBMET03370 | ||
| 0.122 | 0.03 | 0.122 | Estrogen receptor beta antagonist | 0.115 0.039 DBMET00424 0.113 0.041 DBMET03370 | ||
| 0.156 | 0.073 | 0.201 | Melanin inhibitor | 0.167 0.062 DBMET00424 0.156 0.073 DBMET03370 0.201 0.04 DBMET03369 | DBMET03369 | |
| 0.161 | 0.079 | 0.21 | Growth hormone agonist | 0.15 0.087 DBMET00424 0.21 0.055 DBMET03370 | DBMET03370 | |
| 0.144 | 0.073 | 0.267 | Protein kinase stimulant | 0.197 0.043 DBMET00424 0.158 0.063 DBMET03370 0.267 0.022 DBMET03369 | DBMET03369 | |
| 0.104 | 0.035 | 0.189 | Alpha 2a adrenoreceptor antagonist | 0.071 0.057 DBMET00424 0.189 0.015 DBMET03370 | DBMET03370 | |
| 0.139 | 0.085 | 0.386 | NOS3 expression enhancer | 0.14 0.084 DBMET03370 0.386 0.009 DBMET03369 | DBMET03369 | |
| 0.098 | 0.05 | 0.197 | Alpha 2 adrenoreceptor antagonist | 0.197 0.018 DBMET03370 | DBMET03370 | |
| 0.193 | 0.148 | 0.259 | Tyrosine 3 hydroxylase inhibitor | 0.259 0.06 DBMET00424 | DBMET00424 | |
| 0.076 | 0.035 | 0.076 | Dopamine D1 antagonist | 0.064 0.045 DBMET03370 | ||
| 0.042 | 0.005 | 0.042 | Dopamine D1 agonist | 0.034 0.007 DBMET00424 0.039 0.005 DBMET03370 0.037 0.006 DBMET03369 | ||
| 0.124 | 0.09 | 0.207 | Lipid peroxidase inhibitor | 0.12 0.094 DBMET00424 0.176 0.052 DBMET03370 0.207 0.039 DBMET03369 | DBMET03369 | |
| 0.057 | 0.031 | 0.057 | Estrogen agonist | 0.048 0.037 DBMET00424 0.057 0.031 DBMET03370 0.052 0.034 DBMET03369 | ||
| 0.043 | 0.021 | 0.051 | Estrogen receptor beta agonist | 0.051 0.019 DBMET00424 0.028 0.024 DBMET03370 | DBMET00424 | |
| 0.071 | 0.053 | 0.128 | Glycine receptor agonist | 0.067 0.06 DBMET00424 0.128 0.01 DBMET03370 | DBMET03370 | |
| 0.089 | 0.074 | 0.093 | Alpha 2d adrenoreceptor antagonist | 0.093 0.064 DBMET03370 | DBMET03370 | |
| 0.24 | 0.225 | 0.448 | Apoptosis agonist | 0.361 0.133 DBMET03370 0.448 0.092 DBMET03369 | DBMET03369 | |
| 0.073 | 0.06 | 0.073 | Estrogen receptor alpha antagonist | 0.071 0.066 DBMET03370 | ||
| 0.018 | 0.008 | 0.018 | NMDA receptor phencyclidine site antagonist | 0.015 0.011 DBMET00424 0.018 0.008 DBMET03370 | ||
| 0.124 | 0.116 | 0.151 | Adenylate cyclase stimulant | 0.137 0.086 DBMET00424 0.151 0.062 DBMET03370 | DBMET03370 | |
| 0.03 | 0.027 | 0.032 | Estrogen receptor alpha agonist | 0.032 0.025 DBMET00424 0.029 0.027 DBMET03370 | DBMET00424 | |
| 0.184 | 0.182 | 0.43 | Immunomodulator | 0.209 0.153 DBMET03370 0.43 0.036 DBMET03369 | DBMET03369 | |
| 0.083 | 0.084 | 0.106 | Alpha 2c adrenoreceptor antagonist | 0.106 0.06 DBMET03370 | DBMET03370 | |
| 0.064 | 0.069 | 0.166 | Antineoplastic antibiotic | 0.076 0.06 DBMET00424 0.095 0.048 DBMET03370 0.166 0.028 DBMET03369 | DBMET03369 | |
| 0.062 | 0.068 | 0.099 | Na+ K+ transporting ATPase inhibitor | 0.094 0.037 DBMET00424 0.076 0.054 DBMET03370 0.099 0.033 DBMET03369 | DBMET03369 | |
| 0.093 | 0.099 | 0.101 | Electron transport complex I inhibitor | 0.101 0.08 DBMET00424 | DBMET00424 | |
| 0.158 | 0.169 | 0.323 | 5 Hydroxytryptamine release stimulant | 0.323 0.063 DBMET00424 0.18 0.14 DBMET03370 | DBMET00424 | |
| 0.129 | 0.143 | 0.181 | Lipocortins synthesis antagonist | 0.181 0.07 DBMET00424 | DBMET00424 | |
| 0.138 | 0.165 | 0.419 | Immunostimulant | 0.252 0.095 DBMET03370 0.419 0.044 DBMET03369 | DBMET03369 | |
| 0.124 | 0.156 | 0.134 | Ca2+-transporting ATPase inhibitor | 0.134 0.1 DBMET00424 | DBMET00424 | |
| 0.241 | 0.277 | 0.653 | Antiinflammatory | 0.345 0.176 DBMET03370 0.653 0.04 DBMET03369 | DBMET03369 | |
| 0.172 | 0.21 | 0.201 | Vasodilator, peripheral | 0.201 0.175 DBMET03370 | DBMET03370 | |
| 0.047 | 0.088 | 0.06 | Lipocortins synthesis agonist | 0.06 0.035 DBMET03369 | DBMET03369 | |
| 0.014 | 0.059 | 0.031 | Protein 30S ribosomal subunit inhibitor | 0.031 0.012 DBMET03369 | DBMET03369 | |
| 0.172 | 0.218 | 0.294 | 5 Hydroxytryptamine uptake stimulant | 0.294 0.048 DBMET00424 | DBMET00424 | |
| 0.029 | 0.079 | 0.043 | Microtubule stabilization | 0.043 0.037 DBMET03369 | DBMET03369 | |
| 0.228 | 0.281 | 0.282 | Caspase 9 stimulant | 0.282 0.214 DBMET03370 | DBMET03370 | |
| 0.144 | 0.211 | 0.327 | Peptidyltransferase inhibitor | 0.186 0.119 DBMET03370 0.327 0.017 DBMET03369 | DBMET03369 | |
| 0.067 | 0.135 | 0.104 | Adenylate cyclase inhibitor | 0.104 0.081 DBMET03370 | DBMET03370 | |
| 0.061 | 0.13 | 0.114 | Creatine kinase inhibitor | 0.114 0.045 DBMET00424 | DBMET00424 | |
| 0.136 | 0.206 | 0.508 | Hypoglycemic | 0.228 0.091 DBMET03370 0.508 0.014 DBMET03369 | DBMET03369 | |
| 0.052 | 0.123 | 0.083 | Glycine receptor antagonist | 0.083 0.052 DBMET03370 0.083 0.052 DBMET03369 | DBMET03369 | |
| 0.1 | 0.198 | 0.158 | Interleukin 6 antagonist | 0.131 0.124 DBMET00424 0.158 0.078 DBMET03369 | DBMET03369 | |
| 0.034 | 0.139 | 0.046 | Factor III inhibitor | 0.046 0.045 DBMET03369 | DBMET03369 | |
| 0.114 | 0.221 | 0.23 | Vasodilator | 0.204 0.102 DBMET03370 0.23 0.082 DBMET03369 | DBMET03369 | |
| 0.022 | 0.136 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.076 0.021 DBMET03369 | DBMET03369 | |
| 0.048 | 0.175 | 0.174 | Expectorant | 0.093 0.077 DBMET03370 0.174 0.027 DBMET03369 | DBMET03369 | |
| 0.054 | 0.193 | 0.104 | Transcription factor NF kappa B stimulant | 0.104 0.035 DBMET03369 | DBMET03369 | |
| 0.013 | 0.167 | 0.057 | Dopamine D5 agonist | 0.057 0.013 DBMET00424 | DBMET00424 | |
| 0.088 | 0.247 | 0.151 | Interferon gamma antagonist | 0.151 0.077 DBMET03369 | DBMET03369 | |
| 0.08 | 0.242 | 0.299 | Insulin secretagoues | 0.299 0.013 DBMET03369 | DBMET03369 | |
| 0.018 | 0.182 | 0.054 | Antibiotic Aminoglycoside-like | 0.054 0.011 DBMET03369 | DBMET03369 | |
| 0.023 | 0.217 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.025 DBMET03369 | DBMET03369 | |
| 0.135 | 0.341 | 0.326 | Interleukin 2 agonist | 0.326 0.057 DBMET03369 | DBMET03369 | |
| 0.122 | 0.35 | 0.289 | Apoptosis antagonist | 0.21 0.166 DBMET03370 0.289 0.093 DBMET03369 | DBMET03369 | |
| 0.023 | 0.26 | 0.069 | Topoisomerase II alpha inhibitor | 0.069 0.062 DBMET03369 | DBMET03369 | |
| 0.05 | 0.287 | 0.438 | Angiogenesis stimulant | 0.438 0.016 DBMET03369 | DBMET03369 | |
| 0.092 | 0.358 | 0.223 | Cholesterol antagonist | 0.223 0.146 DBMET03369 | DBMET03369 | |
| 0.075 | 0.42 | 0.37 | Antithrombotic | 0.37 0.058 DBMET03369 | DBMET03369 | |
| 0.019 | 0.377 | 0.094 | Topoisomerase I inhibitor | 0.094 0.075 DBMET03369 | DBMET03369 | |
| 0.02 | 0.434 | 0.084 | ATPase (Vacuolar H+) inhibitor | 0.084 0.068 DBMET03369 | DBMET03369 | |
| 0.06 | 0.516 | 0.469 | Antibacterial | 0.469 0.05 DBMET03369 | DBMET03369 | |
| 0.024 | 0.645 | 0.166 | Platelet adhesion inhibitor | 0.166 0.091 DBMET03369 | DBMET03369 | |
| 0.005 | 0.671 | 0.187 | Selectin antagonist | 0.187 0.013 DBMET03369 | DBMET03369 | |
| 0.02 | 0.693 | 0.163 | Tumour necrosis factor alpha release inhibitor | 0.163 0.141 DBMET03369 | DBMET03369 | |
| 0.012 | 0.739 | 0.109 | Cell adhesion inhibitor | 0.109 0.076 DBMET03369 | DBMET03369 | |
| 0.014 | 0.833 | 0.455 | Cyclophilin D inhibitor | 0.455 0.065 DBMET03369 | DBMET03369 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |